Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Indofarma Tbk. (INAF) vs Surya Fajar Capital Tbk. (SFAN)

Indofarma Tbk.Trading
Surya Fajar Capital Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Indofarma Tbk. dan Surya Fajar Capital Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Surya Fajar Capital Tbk. diperdagangkan di Rp2.040 (kapitalisasi pasar 2,76 T, volume 24 jam 79,5 rb). Perbedaan utamanya: Surya Fajar Capital Tbk. jauh lebih besar — sekitar 7,1× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

INAFSFAN
Kapitalisasi Pasar
390,51 M2,76 T
Volume
79,5 rb
Lot
795
Perputaran
162,54 jt
Harga Rata-rata
2.044,54
Nilai Transaksi
162,54 jt

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

INAF
Lihat detail
SFAN
Lihat detail

Tentang Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Selengkapnya di halaman INAF

Tentang Surya Fajar Capital Tbk.

PT Surya Fajar Capital Tbk (the Company) was established based on Notarial Deed No. 12 dated April 5, 2016 of Humberg Lie, S.H., S.E., M.Kn., a public notary in North Jakarta.

Selengkapnya di halaman SFAN